hormonal changes prostatic intraepithelial neoplasia endometrial sarcomas

            MOC AP – General Anatomic Pathology anaplastic large cell lymphoma  malakoplakia avascular necrosis  medulloblastoma choles...
Author: Steven Mathews
0 downloads 3 Views 647KB Size
           

MOC AP – General Anatomic Pathology anaplastic large cell lymphoma  malakoplakia avascular necrosis  medulloblastoma cholesterolosis  meningitis breast; ductal hyperplasia  mesonephric rest breast; stromal lesions  pancreatic endocrine neoplasms breast; benign/reactive/hormonal changes  parvovirus ectopic pregnancy  prostatic intraepithelial neoplasia endometrial sarcomas  refractory anemia esophagitis  renal cell carcinoma subtypes giardiasis  salivary gland neoplasms non-infectious colitis  thymoma Kaposi sarcoma  interstitial lung diseases

MOC AP – Surgical Pathology I  lung; benign tumors; PEComa  meningioma  Paget disease of bone  red cell aplasia  renal cell carcinomas; syndromes  rhabdomyosarcoma  skin; atrophic conditions  solitary fibrous tumor  testis; hematolymphoproliferative disorders  thymoma  ovary; metastatic carcinoma

           

astrocytomas breast; fibrocystic changes breast; ductal carcinoma in situ carcinomas; lung collagenous colitis Cryptococcus endometrial hyperplasia fibroadenoma vs. phyllodes tumor Gleason score hairy cell leukemia hyperparathyroidism inflammatory bowel disease

           

MOC AP – Surgical Pathology II adrenal neoplasms  lung; infections; special stains angiolymphoid hyperplasia with eosinophilia  oral cavity; mesenchymal tumors CNS; demyelinating diseases  ovary; serous tumors CNS; gliomas  parotid gland tumors endometriosis  peripheral nerve sheath tumors follicular lymphoma  primary sclerosing cholangitis Gardner syndrome  salivary gland tumors GI; normal histology  skin; vacuolar interphase dermatitis Gleason patterns  small intestine; neuorendocrine tumors hemangioendothelioma  testis; germ cell tumors hemangioma  thyroid; papillary lesions lipomas

            

MOC AP – Surgical Pathology III bone lesions of the jaw  paragangliomas breast – benign lesions mimicking cancer  PEComas breast – fibrocystic changes  prostate carcinoma breast – malignant neoplasms  prostate – benign lesions mimicking cancer colitis  prostate – normal anatomy & histology hepatitis – clinical lab findings  pulmonary fungal infections HHV-8; lymphoproliferative disorders  soft-tissue sarcomas Hodgkin disease – IHC  testicular tumors – clinical lab findings melanoma  testicular tumors – IHC mesothelial tumors – benign  twin gestation mucosal prolapse syndrome  urinary bladder – benign lesions myometrial lesions – benign  vasculitides oral mucosa lesions

            

MOC AP – Cytopathology I – Gynecologic & Non-Gynecologic adenocarcinoma; ascites  LSIL Pneumocystis  BAL benign mixed tumor/pleomorphic adenoma  pancreatic cytology Bethesda system  parotid gland FNA bile duct FNA cytology  pelvic washings cytology Candida  pulmonary fungal infections carcinoma; bronchial wash  sputum adequacy cervical cancer screening guidelines  squamous cell carcinoma; cervix cervicitis  thyroid carcinoma cholangiocarcinoma  thyroid nodule FNA CLIA; Pap test retention  urine contamination hepatocellular carcinoma  urine cytology; infectious agents HSIL

           

MOC AP – Cytopathology II – Gynecologic adenocarcinoma  HSIL; management guidelines adenocarcinoma in situ  hyperkeratosis ASCUS management  LSIL atrophy  LSIL management atypical glandular cells, management  melanoma Bethesda system, adequacy  Pap; benign cells Candida, trichomonas  Pap; endometrial cells cervical cancer screening guidelines  Reactive / reparative changes endometrial adenocarcinoma  small cell carcinoma glycogen accumulation  squamous carcinoma Herpesvirus  untreated LSIL HSIL

           

MOC AP – Cytopathology III - Non-Gynecologic BAL; fungal infection  pancreatic carcinoma cerebrospinal fluid; fungal infections  pancreatic cystic neoplasms ciliocytophthoria  pancreatic benign neoplasms delayed specimen processing; fixation  pancreatic pseudocysts; fluid chemistries esophageal brushings  parotid FNA; malignant neoplasms GI stromal tumor  peritoneal washings; benign cells Head and neck FNA; benign cysts  pleural fluid; malignant cells liver FNA; malignant neoplasms  Pneumocystis lung adenocarcinoma; molecular testing  thyroid FNA; benign lung FNA; benign neoplasms  thyroid FNA; malignant neoplasms (2) lymph node FNA; lymphoid neoplasms  urine casts melanoma  urine; malignant neoplasms

           

MOC AP – Bone/Soft Tissue angiomyofibroblastoma  malignant chondroid tumors arthritis  malignant osteogenic tumors atypical fibroxanthoma; pleomorphic sarcoma  malignant vascular tumors benign fibrous/myofibroblastic lesions  metabolic disorders of bone benign osteogenic tumors  osteomyelitis benign peripheral nerve sheath tumors  paraganglioma bone infarct  perivascular tumors connective tissue tumors  reactive soft tissue lesions simulating sarcoma fibrous dysplasia  rhabdomyosarcoma leiomyosarcoma  small round cell tumors lipoma and variants  synovial sarcoma liposarcoma

      

adenomas adenosis atypical lobular hyperplasia columnar cell change ductal carcinoma in situ and variants ductal hyperplasia, usual and atypical HER-2 IHC

MOC AP – Breast I  invasive ductal carcinoma and variants  inflammatory/reactive lesions  mesenchymal tumors  mixed epithelial and stromal tumors  papilloma  radial scar; complex sclerosing lesion

          

adenosis Bloom-Richardson grading collagenous spherulosis DCIS vs LCIS ductal carcinoma in situ epithelial hyperplasias Her-2/neu IHC infiltrating carcinoma infiltrating ductal carcinoma; variants inflammatory/reactive lesions lobular carcinoma in situ

         

adenosis variants atypical ductal lesions benign ductal lesions core biopsy findings requiring re-excision detecting stromal invasions ER, PR, Her2 interpretations fibroadenomas fibrocystic changes flat epithelial atypia grading of breast cancers

           

amyloid aneurysms and dissections cardiac catheterization complications cardiac tumors cardiac valvular lesions Churg-Strauss angiitis Dirofilaria endomyocardial biopsy; heart allograft hypertensive cerebrovascular disease hypertrophic cardiomyopathy infectious vasculitis infective endocarditis

MOC AP – Breast II  malignant mesenchymal tumors  mammographic abnormalities  microarray gene analysis  mixed epithelial and stromal tumors  nipple lesions  papillary lesions  physiological changes in normal breast  pseudoangiomatous stromal hyperplasia  radial scar  therapy induced changes

MOC AP – Breast III  gynecomastia  inflammatory lesions  invasive ductal carcinoma & variants  neuroendocrine differentiation in carcinoma  Paget disease  phyllodes tumors  risk of breast cancer  sentinel lymph nodes  spindle cell metaplastic carcinoma

MOC AP – Cardiovascular  inflammatory cardiomyopathies  ischemic heart disease  Kawasaki disease  myocardial infarction  polyarteritis nodosa  renal artery stenosis  rheumatic fever  sarcoidosis  vascular thrombosis  vascular tumors of intermediate malignancy  vasculitis

          

MOC AP – Dermatopathology I - Non-Neoplastic alterations of dermal collagen (scar, keloid,  panniculitis scleroderma) bullous and pustular diseases (pemphigus)  pediculosis celiac disease  psoriasiform dermatitis dermal fungal infections  sentinel lymph nodes; normal histology dermatitis herpetiformis; subepidermal bullae  spongiotic dermatitis diffuse dermal inflammation (Sweet syndrome, etc.)  stasis dermatitis granulomatous dermatitis  vacuolar interphase dermatitis herpes  vacuolar interphase dermatitis; IF hyperpigmentation  vasculitis Langerhans cells  viral infections lichenoid dermatitis

MOC AP – Dermatopathology II - Neoplastic  malignant vascular tumors  melanoma  melanoma in situ  melanoma; variants  metastatic carcinomas  metastatic melanoma; targeted therapy  neuroendocrine carcinoma  premalignant epidermal tumors  sebaceous adenoma  vascular tumors of intermediate malignancy

         

atypical fibroxanthoma benign adnexal tumors benign epidermal tumors benign vascular tumors Breslow measurement cutaneous leukemia dermal melanocytic lesions dermatofibroma histiocytic tumors malignant soft tissue tumors

          

MOC AP – Endocrine adrenal hypofunction; infections  pheochromocytoma adrenal metastatic carcinoma  pituitary adenoma adrenocortical adenoma  pituitary histology adrenocortical carcinoma  thyroid anaplastic carcinoma adrenocortical carcinoma vs renal cell carcinoma  thyroid FNA; false positive adrenocortical hyperplasia  thyroid follicular adenoma multiple endocrine neoplasia  thyroid follicular carcinoma pancreatic neuroendocrine tumor  thyroid medullary carcinoma paraganglion  thyroid nodule; gross sampling parathyroid carcinoma  thyroid oncocytic carcinoma parathyroid anatomy and histology  thyroid papillary carcinoma

            

MOC AP – Gastrointestinal/Liver/Biliary I anal neoplasms  hepatobiliary neoplastic cysts biliary tract diseases  hepatocellular carcinoma celiac disease  immunodeficiency colitis; drugs  intestinal parasites esophagus; benign lesions  microsatellite-unstable colon cancers; IHC esophagus; infections  pancreatic neuroendocrine tumors esophagus; mesenchymal tumors  pre-neoplastic lesions of esophagus esophagus; metaplasia  primary biliary cirrhosis esophagus; pre-cancerous lesions  regenerative nodule vs hepatocellular carcinoma gastric carcinoma  sarcomas gastrinomas  small intestines; infections GI tract lymphomas  small intestines; adenomas Helicobacter gastritis

           

MOC AP – Gastrointestinal/Liver/Biliary II anal intraepithelial neoplasia  mesenchymal tumors of GI tract benign liver masses  metastatic carcinoma; IHC colitis  neuroendocrine tumors of GI tract colorectal polyps  pancreatic adenoma diverticular disease  pancreatic carcinoma esophagitis  pancreatic cystic neoplasms esophagus; benign tumors  pancreatic neuroendocrine tumors familial colorectal cancer syndromes  preneoplastic lesions of esophagus gastritis  reactive gastropathy Hepatocellular carcinoma; Hepatitis C; cirrhosis  small intestines; non-neoplastic disorders hepatocellular carcinoma; IHC  steatohepatitis liver; vascular disorders/tumors

         

MOC AP – Gastrointestinal/Liver/Biliary III adenomatous colon polyps and cancer  liver – normal anatomy and histology amyloidosis  liver – viral infections colitis  Lynch syndrome esophagitis  mesenteric lymphadenitis gastritis  parasitic infections – liver Helicobacter gastritis  parasitic infections – small bowel hepatitis  small bowel obstruction – causes intestinal polyps and pseudopolyps  viral infections of the GI tract liver transplantation  Whipple procedure liver – granulomas

          

          

          

Gleason score mimickers of prostate cancer nephrosclerosis pediatric renal tumors polycystic kidney disease polyomavirus prostate adenocarcinoma prostate; IHC prostate; normal histology pyelonephritis renal allograft rejection

MOC AP – Genitourinary I  renal cell carcinoma  renal cell carcinoma; subtypes  renal papillae lesions  renal tumors; benign  spermatocytic seminoma  testicular biopsy for infertility  testicular germ cell tumors  urinary bladder; non-neoplastic lesions  urinary bladder; reactive changes  urothelial carcinoma  urothelial papillomas

MOC AP – Genitourinary II acute tubular necrosis  prostate; normal histology adult renal tumors  prostate; reactive changes angiomyxoma  prostatectomy specimens; incidental findings germ cell tumors  pyelonephritis infertility  renal neoplasms; genetic syndromes lysosomal storage diseases; Fanconi syndrome  sex cord stromal tumors mesonephric rests and hyperplasia  urinary bladder; neoplasms, benign and malignant neuroendocrine carcinoma  urinary bladder; non-neoplastic lesions pediatric renal tumors  urothelial carcinoma; variants penis; neoplastic and non-neoplastic  urothelial tract; inflammatory and reactive lesions prostate carcinoma

MOC AP – GYN/Placenta I adenocarcinoma of cervix  fetal membrane and disc abnormalities atypical endometrial hyperplasia  multiple pregnancy placenta cervical metaplasia  myometrial soft tissue tumors cervix histology  ovarian germ cell tumors endocervical biopsy; benign/reactive changes  ovary; metastatic carcinoma endometrial carcinoma; subtypes  ovary; small cell carcinoma endometrial carcinosarcoma  serous tumors of ovary endometrium; hyperplasias  squamous intraepithelial lesions endometrium; iatrogenic patterns  villitis and intervillositis; infectious endometrium; metaplasias  vulvar soft tissue tumors endometrium; normal patterns

           

adenoid basal carcinoma BRCA-1 mutations; GYN tumors carcinomas metastatic to ovaries cervical dysplasia disseminated peritoneal leiomyomatosis endocervical adenocarcinoma endometrial adenocarcinoma endometrial hyperplasia endometrial metaplasia endometrial polyps endometrioid carcinoma; FIGO grading endometritis

MOC AP – GYN/Placenta II  fallopian tubes; inflammatory/infectious disorders  germ cell tumors  maternal hypertension; placental findings  mesonephric rests  molar pregnancy  ovarian mucinous tumors; survival  ovarian serous tumors; mutations  PAX-8  Peutz-Jeghers syndrome; ovarian neoplasms  polycystic ovaries  umbilical cord; infections  uterine smooth muscle tumors MOC AP – GYN/Placenta III  fallopian tube neoplasms  fallopian tubes; BRCA1 mutations  lichen scleroses  ovarian germ cell tumors  ovarian surface epithelial tumors  ovarian teratomas; grading  ovary; metastatic tumors  papillary tumors of the peritoneum  twin gestation  uterine smooth muscle tumors; metastases

          

cervical intraepithelial neoplasia cervical lesions – benign eclampsia and atherosis endometrial hyperplasia endometrial metaplasias endometrial stromal nodule endometrial stromal sarcoma endometritis endometrium; iatrogenic patterns endometrium; neoplastic endometrium; non-neoplastic

           

MOC AP – Head & Neck adipose tumors  normal oral histology bone infarct  nose and sinuses; fungal infections branchial cleft cyst  odontogenic cysts ectopic thyroid  odontogenic neoplasms granular cell tumor  phycomycosis Kimura disease  pleomorphic adenoma larynx; benign neoplasms  radiation effect larynx; squamous dysplasia; carcinoma  salivary gland tumors; malignant lymphoepithelial cysts  salivary gland; benign neoplasms metabolic disorders of bone; hyperparathyroidism  thyroid; medullary carcinoma nasopharyngeal carcinoma  Warthin tumor non-neoplastic lesions; oral cavity

           

acute diffuse proliferative GN AIDS nephropathy Alport syndrome amyloidosis cryoglobulinemic GN dense deposit disease diffuse extracapillary proliferative GN focal segmental glomerular sclerosis Goodpasture syndrome Henoch-Schönlein purpura lupus nephropathies membranoproliferative GN

          

acute diffuse intracapillary proliferative GN adult polycystic kidney disease Alport syndrome amyloidosis anti-GBM nephritis arterial and arteriolar nephrosclerosis developmental/congenital lesions Fabry disease fibrillary GN HIV-associated nephropathy hydronephrosis

          

MOC AP – Medical Renal I  membranous GN  minimal change nephrotic syndrome  monoclonal gammopathy associated renal diseases  obstructive kidney disease  polyoma virus  posttransplant lymphoproliferative disorder  pyelonephritis  renal allograft rejection  serum complement in renal diseases  thrombotic microangiopathy  Wegener granulomatosis

MOC AP – Medical Renal II  IgA nephropathy  lupus nephropathies  membranoproliferative GN  minimal change nephrotic syndrome  nephrotic syndrome with hematuria  paraneoplastic syndrome  renal allograft rejection  renal infarction  renal transplant rejection; IHC  thrombotic microangiopathy

MOC AP – Molecular Pathology alveolar rhabdomyosarcoma  KRAS point mutation detection BRCA1mutations; cancer risk  lung adenocarcinoma; mutations clear cell sarcoma  lung cancer; FISH CML; Gleevec  neuroblastoma colon cancer; microsatellite instability  neurocutaneous syndromes false negative results; paraffin embedded tissue  polyposis syndromes FISH interpretation  prostate cancer FISH, HER2  quality control; sample contamination gel electrophoresis; sample degradation; QC  renal carcinomas high grade embryonal tumor  thyroid carcinomas hyperplasia vs lymphoma

            

       

adenocarcinoma bronchiectasis carcinoid tumor clear cell (sugar) tumor fungal infections; special stains hamartoma hemangioendothelioma hypersensitivity pneumonitis interstitial pneumonias IV drug abuse juvenile squamous papillomas lipid pneumonia mesothelioma

chronic rejection; histology corneal transplant; donor criteria graft derived ABO antibodies graft-versus-host disease GVHD; liver GVHD; skin HLA system; inheritance hyperacute rejection

MOC AP – Pulmonary-Mediastinal  mesothelioma  mesothelioma; IHC  mycobacterial infections  organizing pneumonia  parasitic infections  PEComa  pulmonary hypertension  respiratory bronchiolitis  sarcoid  small cell carcinoma  solitary fibrous tumor  thymoma

MOC AP – Transplant Pathology  passenger lymphocyte syndrome  post-transplant viral infection  post-transplant; pulmonary infections  prevention/treatment of transplant rejection  second renal allograft rejection  transplant glomerulopathy  types of transplanted tissues

Suggest Documents